Results 21 to 30 of about 1,515,812 (286)
Type 1 diabetes mellitus: much progress, many opportunities.
Journal of Clinical Investigation, 2021 As part of the centennial celebration of insulin's discovery, this review summarizes the current understanding of the genetics, pathogenesis, treatment, and outcomes in type 1 diabetes (T1D).
A. Powers
semanticscholar +1 more source
Collagenase Isoforms for Pancreas Digestion
Cell Transplantation, 2009 The available information concerning the characteristics and composition of collagenase batches, which are effective in the digestion of human pancreas for islet transplants, is scarce and incomplete.
Federico Bertuzzi +7 more
doaj +1 more source
Fulminant Type 1 Diabetes Mellitus
Endocrine Journal, 2006 Fulminant type 1 diabetes is a novel subtype characterized by a markedly rapid progression and almost complete destruction of pancreatic beta cells. The number of patients in Japan has been speculated to be 5,000-7,000. A marked decrease of beta cells in addition to alpha cells and mononuclear cell infiltration both in the endocrine and exocrine ...
Akihisa, Imagawa, Toshiaki, Hanafusa
openaire +4 more sources
Nutrition & Diabetes, 2015 Background:Omentin-1 is an anti-inflammatory adipokine produced preferentially by visceral adipose tissue. Plasma levels of omentin-1 are decreased in obesity and other insulin-resistant states.
J. Lesná +7 more
semanticscholar +1 more source
Table 1: Type 1 diabetes mellitus and cardiovascular disease
Revista de la Sociedad Argentina de Diabetes, 2020 The leading cause of death in type 1 diabetes mellitus (T1DM) is cardiovascular. The duration of diabetes is one of the most important predictors for acute myocardial infarction (AMI), along with low-density lipoprotein cholesterol (cLDL) and HbA1c ...
Lázaro González +12 more
doaj +1 more source
Cardiovascular risk in type 1 diabetes mellitus
Indian Journal of Endocrinology and Metabolism, 2013 Commonly cardiovascular risk (CVR) is linked to type 2 diabetes mellitus as this type is known to be part of the metabolic syndrome, which includes other cardiovascular factors such as hypertension, dyslipidemia.
Ines Ben Hadj Slama Slim
doaj +1 more source
Liver Damage in Type 1 Diabetes Mellitus
Российский журнал гастроэнтерологии, гепатологии, колопроктологии, 2021 Aim. An up-to-date review of the prevalence, pathogenesis, diagnosis and management of hepatological complications of type 1 diabetes mellitus (T1D).Key points. Diabetes type 1 causes a markedly more common liver injury than traditionally assumed.
A. O. Bueverov, A. V. Zilov
doaj +1 more source
Continuous glucose monitoring: A review of the evidence in type 1 and 2 diabetes mellitus
Diabetic Medicine, 2021 Continuous glucose monitoring (CGM) is becoming widely accepted as an adjunct to diabetes management. Compared to standard care, CGM can provide detailed information about glycaemic variability in an internationally standardised ambulatory glucose ...
Rose Lin +4 more
semanticscholar +1 more source
Bone remodeling in type 1 diabetes mellitus
Бюллетень сибирской медицины, 2018 The aim of the study is to assess the effect of changes in the body in men and women with type 1 diabetes on the state of bone mineral density and metabolic rate and determine the directionality of changes in serum markers of bone remodeling and bone ...
S. S. Safarova
doaj +1 more source
Type 1 diabetes mellitus as a disease of the β-cell (do not blame the immune system?)
Nature Reviews Endocrinology, 2020 Type 1 diabetes mellitus is believed to result from destruction of the insulin-producing β-cells in pancreatic islets that is mediated by autoimmune mechanisms. The classic view is that autoreactive T cells mistakenly destroy healthy (‘innocent’) β-cells.
B. Roep +3 more
semanticscholar +1 more source